Published in J Clin Invest on May 01, 1985
Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer (2009) 5.31
Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci U S A (1989) 4.81
Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci U S A (1988) 2.08
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene (2012) 2.03
Functional targeting of the MUC1 oncogene in human cancers. Cancer Biol Ther (2009) 1.39
Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer (2005) 1.28
Gene-based vaccines and immunotherapeutics. Proc Natl Acad Sci U S A (2004) 1.14
Current approaches and challenges in monitoring treatment responses in breast cancer. J Cancer (2014) 1.13
An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma. Br J Cancer (1995) 0.98
Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA. Br J Cancer (1988) 0.90
Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511. Br J Cancer (1989) 0.87
Circulating tumour markers in breast cancer. Eur J Nucl Med Mol Imaging (2004) 0.86
Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2. Br J Cancer (1989) 0.85
A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer. Br J Cancer (1986) 0.85
CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. BMC Vet Res (2012) 0.84
Transmembrane mucins as novel therapeutic targets. Expert Rev Endocrinol Metab (2011) 0.82
Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form. PLoS One (2014) 0.81
Circulating CA 15-3 antigen levels in non-mammary malignancies. Br J Cancer (1989) 0.78
Serum human alpha-lactalbumin as a marker for breast cancer. Br J Cancer (1990) 0.78
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics. Biomed Res Int (2015) 0.77
Polymorphic epithelial mucin from the sera of advanced breast cancer patients--isolation and partial characterisation. Br J Cancer (1990) 0.77
Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. Int J Clin Oncol (2014) 0.75
Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem (1974) 18.33
Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. Biochemistry (1978) 9.04
Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell (1975) 4.32
Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer (1981) 3.90
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma (1984) 3.74
Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology. Cancer (1981) 3.07
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol (1982) 2.69
Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol (1983) 2.64
Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer (1981) 2.53
A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A (1981) 2.00
Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet (1982) 1.76
Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68
Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res (1979) 1.62
Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res (1983) 1.60
Human alpha-lactalbumin: measurement in serum and in breast cancer organ cultures by radioimmunoassay. Science (1975) 1.53
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol (1981) 1.46
Circulating human mammary epithelial antigens in breast cancer. Proc Natl Acad Sci U S A (1982) 1.26
Clinical correlation between CEA and breast cancer. Cancer (1978) 1.19
A human breast tissue-associated antigen detected by a monoclonal antibody. J Natl Cancer Inst (1983) 1.16
Glycolipid-bound sialic acid in serum: increased levels in mice and humans bearing mammary carcinomas. Proc Natl Acad Sci U S A (1977) 1.10
Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somatic Cell Genet (1983) 0.98
Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma. Cancer Res (1983) 0.97
Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22. Cancer Res (1984) 0.96
Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma. Cancer (1978) 0.93
Serum sialyltransferase and 5'-nucleotidase as reliable biomarkers in women with breast cancer. J Natl Cancer Inst (1980) 0.92
Simultaneous assays of cancer associated antigens in benign and malignant breast diseases. Cancer (1977) 0.89
Sodium butyrate induction of milk-related antigens in human MCF-7 breast carcinoma cells. Cancer Res (1984) 0.89
Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22. Cancer Res (1983) 0.87
Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy. Cancer (1980) 0.87
A new proteolipid apparently associated with cancer. Proc Soc Exp Biol Med (1971) 0.82
Resetting central and peripheral circadian oscillators in transgenic rats. Science (2000) 8.63
Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A (2001) 4.84
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res (1999) 4.17
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma (1984) 3.74
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25
Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature (2001) 3.24
Nucleotide sequence of the tobacco mosaic virus (tomato strain) genome and comparison with the common strain genome. J Biochem (1984) 2.93
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol (1994) 2.77
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med (1996) 2.74
Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol (1989) 2.61
Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int (2006) 2.57
Hop stunt viroid: molecular cloning and nucleotide sequence of the complete cDNA copy. Nucleic Acids Res (1983) 2.54
Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (1995) 2.54
Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst (1994) 2.50
Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation. Cancer Res (1983) 2.46
THE BACTERIOLOGICAL STANDARDIZATION OF DISINFECTANTS: SOME FURTHER SUGGESTIONS. Am J Public Health (N Y) (1914) 2.33
Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med (1991) 2.31
Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature (1998) 2.29
A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. Clin Cancer Res (2000) 2.28
A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood (1994) 2.27
Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet (1993) 2.23
Nucleotide sequence of cucumber pale fruit viroid: homology to hop stunt viroid. Nucleic Acids Res (1984) 2.22
Friends' influence of adolescents' adjustment to school. Child Dev (1995) 2.21
Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol (1992) 2.19
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer (2006) 2.14
Specific phases of root hair attachment in the Rhizobium trifolii-clover symbiosis. Appl Environ Microbiol (1984) 2.10
Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci U S A (1988) 2.08
Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis (1995) 2.07
Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut (2000) 2.06
Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res (2000) 2.06
Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci U S A (1989) 2.05
Chlorophyll b and phycobilins in the common ancestor of cyanobacteria and chloroplasts. Nature (1999) 1.99
Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1980) 1.97
Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol (1986) 1.94
The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med (1995) 1.90
Replication of the escherichia coli K12 chromosome. Proc Natl Acad Sci U S A (1967) 1.88
The rubble-pile asteroid Itokawa as observed by Hayabusa. Science (2006) 1.87
Establishment of a simple and practical procedure applicable to therapeutic angiogenesis. Circulation (1999) 1.83
Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc Natl Acad Sci U S A (1995) 1.79
New prognostic factors for breast cancer recurrence. Semin Oncol (2001) 1.77
Early endoscopy. A guide to therapy for acute hemorrhage in the upper gastrointestinal tract. Arch Surg (1973) 1.77
The 5'-terminal sequence of TMV RNA. Question on the polymorphism found in vulgare strain. FEBS Lett (1983) 1.75
Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Oncogene (2008) 1.74
Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy (2008) 1.73
Genetic analysis of the DNA-dependent protein kinase reveals an inhibitory role of Ku in late S-G2 phase DNA double-strand break repair. J Biol Chem (2001) 1.73
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst (1988) 1.73
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol (2000) 1.72
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. Clin Cancer Res (2001) 1.72
Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut (2001) 1.71
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol (1993) 1.71
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study. Cancer Res (2001) 1.71
Relation between diet and protozoal population in the rumen. Br J Nutr (1973) 1.69
Stimulation of clover root hair infection by lectin-binding oligosaccharides from the capsular and extracellular polysaccharides of Rhizobium trifolii. J Bacteriol (1984) 1.69
A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol (2001) 1.67
Measurement of yeast intracellular pH by image processing and the change it undergoes during growth phase. J Biotechnol (1995) 1.66
Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res (1980) 1.66
Chromosome replication in Escherichia coli K12 mutant affected in the process of DNA initiation. Genetics (1971) 1.64
A revised replication cycle for viroids: the role of longer than unit length RNA in viroid replication. Mol Gen Genet (1984) 1.64
Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism (2000) 1.63
Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood (1995) 1.62
Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice. J Gastroenterol (2001) 1.62
Techniques, indications and results of intraoperative radiotherapy of advanced cancers. Radiology (1975) 1.62
Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc Natl Acad Sci U S A (1997) 1.61
Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice. Nephron (1998) 1.60
Bacteriophage-induced acidic heteropolysaccharide lyases that convert the acidic heteropolysaccharides of Rhizobium trifolii into oligosaccharide units. J Bacteriol (1984) 1.60
Molecular cloning and nucleotide sequence of the 30K and the coat protein cistron of TMV (tomato strain) genome. Nucleic Acids Res (1983) 1.60
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol (1998) 1.59
Spatial and temporal control of gene therapy using ionizing radiation. Nat Med (1995) 1.59
A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 1.59
Clinical significance of "cannibalism" in urinary cytology of bladder cancer. Acta Cytol (1998) 1.59
Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci U S A (1997) 1.59
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med (1989) 1.59
Correlation of cytotoxicity with incorporation of ara-C into DNA. J Biol Chem (1980) 1.58
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol (2009) 1.58
CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity (2000) 1.57
Analyses of ornithine decarboxylase antizyme mRNA with a cDNA cloned from rat liver. J Biochem (1990) 1.57
Major quantitative trait locus on chromosome 2 for glucose tolerance in diabetic SMXA-5 mouse established from non-diabetic SM/J and A/J strains. Diabetologia (2006) 1.55
Thallium-201 SPECT of adjacent intracranial tumours: a contrast in thallium kinetics. Neuroradiology (1999) 1.55
Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest (1988) 1.53
Specific cessation of minus-strand RNA accumulation at an early stage of tobacco mosaic virus infection. J Virol (1991) 1.53
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest (1996) 1.52
Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus. Proc Natl Acad Sci U S A (1978) 1.51
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol (1992) 1.51
CT is useful for identifying patients with complicated appendicitis. Dig Liver Dis (2004) 1.50
Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proc Natl Acad Sci U S A (1984) 1.50
Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int (1999) 1.50
Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci U S A (1990) 1.50
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther (1998) 1.50
Acute disseminated encephalomyelitis associated with poliomyelitis vaccine. Pediatr Neurol (2000) 1.50
Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol (1999) 1.47
Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasonography. J Urol (1990) 1.47
Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer (1995) 1.47
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study. Br J Dermatol (2013) 1.46
Usefulness of transcutaneous Doppler jugular venous echo to predict pulmonary hypertension in COPD patients. Eur Respir J (2001) 1.46
The dorsiflexion-eversion test for diagnosis of tarsal tunnel syndrome. J Bone Joint Surg Am (2001) 1.46